Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121


A multimodality test to guide the management of patients with a pancreatic cyst.

Springer S, Masica DL, Dal Molin M, Douville C, Thoburn CJ, Afsari B, Li L, Cohen JD, Thompson E, Allen PJ, Klimstra DS, Schattner MA, Schmidt CM, Yip-Schneider M, Simpson RE, Fernandez-Del Castillo C, Mino-Kenudson M, Brugge W, Brand RE, Singhi AD, Scarpa A, Lawlor R, Salvia R, Zamboni G, Hong SM, Hwang DW, Jang JY, Kwon W, Swan N, Geoghegan J, Falconi M, Crippa S, Doglioni C, Paulino J, Schulick RD, Edil BH, Park W, Yachida S, Hijioka S, van Hooft J, He J, Weiss MJ, Burkhart R, Makary M, Canto MI, Goggins MG, Ptak J, Dobbyn L, Schaefer J, Sillman N, Popoli M, Klein AP, Tomasetti C, Karchin R, Papadopoulos N, Kinzler KW, Vogelstein B, Wolfgang CL, Hruban RH, Lennon AM.

Sci Transl Med. 2019 Jul 17;11(501). pii: eaav4772. doi: 10.1126/scitranslmed.aav4772.


Quality of Life Following Major Laparoscopic or Open Pancreatic Resection.

Torphy RJ, Chapman BC, Friedman C, Nguyen C, Bartsch CG, Meguid C, Ahrendt SA, McCarter MD, Del Chiaro M, Schulick RD, Edil BH, Gleisner A.

Ann Surg Oncol. 2019 Sep;26(9):2985-2993. doi: 10.1245/s10434-019-07449-x. Epub 2019 Jun 21.


Cystic pancreatic neuroendocrine tumors: A distinctive subgroup with indolent biological behavior? A systematic review and meta-analysis.

Zhu JK, Wu D, Xu JW, Huang X, Jiang YY, Edil BH, Li M, Hu SY, Zhan HX.

Pancreatology. 2019 Jul;19(5):738-750. doi: 10.1016/j.pan.2019.05.462. Epub 2019 May 27.


CD28H expression identifies resident memory CD8 + T cells with less cytotoxicity in human peripheral tissues and cancers.

Tian Y, Sun Y, Gao F, Koenig MR, Sunderland A, Fujiwara Y, Torphy RJ, Chen L, Edil BH, Schulick RD, Zhu Y.

Oncoimmunology. 2018 Nov 5;8(2):e1538440. doi: 10.1080/2162402X.2018.1538440. eCollection 2019.


ZIP4 Promotes Muscle Wasting and Cachexia in Mice With Orthotopic Pancreatic Tumors by Stimulating RAB27B-Regulated Release of Extracellular Vesicles From Cancer Cells.

Yang J, Zhang Z, Zhang Y, Ni X, Zhang G, Cui X, Liu M, Xu C, Zhang Q, Zhu H, Yan J, Zhu VF, Luo Y, Hagan JP, Li Z, Fang J, Jatoi A, Fernandez-Zapico ME, Zheng L, Edil BH, Bronze MS, Houchen CW, Li YP, Li M.

Gastroenterology. 2019 Feb;156(3):722-734.e6. doi: 10.1053/j.gastro.2018.10.026. Epub 2018 Oct 17.


Pomalidomide Inhibits PD-L1 Induction to Promote Antitumor Immunity.

Fujiwara Y, Sun Y, Torphy RJ, He J, Yanaga K, Edil BH, Schulick RD, Zhu Y.

Cancer Res. 2018 Dec 1;78(23):6655-6665. doi: 10.1158/0008-5472.CAN-18-1781. Epub 2018 Oct 12.


Perioperative and Survival Outcomes Following Neoadjuvant FOLFIRINOX versus Gemcitabine Abraxane in Patients with Pancreatic Adenocarcinoma.

Chapman BC, Gleisner A, Rigg D, Messersmith W, Paniccia A, Meguid C, Gajdos C, McCarter MD, Schulick RD, Edil BH.

JOP. 2018 Mar;19(2):75-85. Epub 2018 Mar 30.


Comparing Short-term and Oncologic Outcomes of Minimally Invasive Versus Open Pancreaticoduodenectomy Across Low and High Volume Centers.

Torphy RJ, Friedman C, Halpern A, Chapman BC, Ahrendt SS, McCarter MM, Edil BH, Schulick RD, Gleisner A.

Ann Surg. 2018 May 16. doi: 10.1097/SLA.0000000000002810. [Epub ahead of print]


Utility of Viscoelastic Assays Beyond Coagulation: Can Preoperative Thrombelastography Indices Predict Tumor Histology, Nodal Disease, and Resectability in Patients Undergoing Pancreatectomy?

Moore HB, Paniccia A, Lawson PJ, Torphy RJ, Nydam TL, Moore EE, McCarter MD, Schulick RD, Edil BH.

J Am Coll Surg. 2018 Jul;227(1):55-62. doi: 10.1016/j.jamcollsurg.2018.03.031. Epub 2018 Mar 30.


Perioperative outcomes and survival following neoadjuvant stereotactic body radiation therapy (SBRT) versus intensity-modulated radiation therapy (IMRT) in pancreatic adenocarcinoma.

Chapman BC, Gleisner A, Rigg D, Meguid C, Goodman K, Brauer B, Gajdos C, Schulick RD, Edil BH, McCarter MD.

J Surg Oncol. 2018 Apr;117(5):1073-1083. doi: 10.1002/jso.25004. Epub 2018 Feb 15.


Comparison of laparoscopic to open pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma.

Chapman BC, Gajdos C, Hosokawa P, Henderson W, Paniccia A, Overbey DM, Gleisner A, Schulick RD, McCarter MD, Edil BH.

Surg Endosc. 2018 May;32(5):2239-2248. doi: 10.1007/s00464-017-5915-0. Epub 2017 Oct 24.


Laparoscopic pancreaticoduodenectomy: changing the management of ampullary neoplasms.

Chapman BC, Gleisner A, Ibrahim-Zada I, Overbey DM, Paniccia A, Meguid C, Brauer B, Gajdos C, McCarter MD, Schulick RD, Edil BH.

Surg Endosc. 2018 Feb;32(2):915-922. doi: 10.1007/s00464-017-5766-8. Epub 2017 Aug 4.


Blockade of CD112R and TIGIT signaling sensitizes human natural killer cell functions.

Xu F, Sunderland A, Zhou Y, Schulick RD, Edil BH, Zhu Y.

Cancer Immunol Immunother. 2017 Oct;66(10):1367-1375. doi: 10.1007/s00262-017-2031-x. Epub 2017 Jun 16.


Portal Venous Stenting in Locally Advanced Pancreatic Cancer to Decrease Risk of Thrombosis Before Irreversible Electroporation: A Case Report and Review of the Literature.

Monroe JF, Johnson T, Edil BH.

J Pancreat Cancer. 2017 Mar 1;3(1):15-18. doi: 10.1089/pancan.2016.0022. eCollection 2017.


Is Chemical Pyloroplasty Necessary for Minimally Invasive Esophagectomy?

Stewart CL, Wilson L, Hamm A, Bartsch C, Boniface M, Gleisner A, Mitchell JD, Weyant MJ, Meguid R, Gajdos C, Edil BH, McCarter M.

Ann Surg Oncol. 2017 May;24(5):1414-1418. doi: 10.1245/s10434-016-5742-x. Epub 2017 Jan 5.


Impact of Facility Type and Surgical Volume on 10-Year Survival in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma.

Chapman BC, Paniccia A, Hosokawa PW, Henderson WG, Overbey DM, Messersmith W, McCarter MD, Gleisner A, Edil BH, Schulick RD, Gajdos C.

J Am Coll Surg. 2017 Mar;224(3):362-372. doi: 10.1016/j.jamcollsurg.2016.11.011. Epub 2016 Dec 5.


Evolving Trends Towards Minimally Invasive Surgery for Solid-Pseudopapillary Neoplasms.

Stewart CL, Meguid C, Chapman B, Schulick R, Edil BH.

Ann Surg Oncol. 2016 Dec;23(13):4165-4168. Epub 2016 Aug 10.


NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016.

VanderWalde N, Jagsi R, Dotan E, Baumgartner J, Browner IS, Burhenn P, Cohen HJ, Edil BH, Edwards B, Extermann M, Ganti AK, Gross C, Hubbard J, Keating NL, Korc-Grodzicki B, McKoy JM, Medeiros BC, Mrozek E, O'Connor T, Rugo HS, Rupper RW, Shepard D, Silliman RA, Stirewalt DL, Tew WP, Walter LC, Wildes T, Bergman MA, Sundar H, Hurria A.

J Natl Compr Canc Netw. 2016 Nov;14(11):1357-1370.


Laparoscopic Spleen-Preserving Total Pancreatectomy for a Main-Duct Intraductal Papillary Mucinous Neoplasm.

Chapman BC, Paniccia A, Ryan C, Schulick RD, Edil BH.

Ann Surg Oncol. 2017 Feb;24(2):560. doi: 10.1245/s10434-016-5481-z. Epub 2016 Sep 2.


Total laparoscopic pancreaticoduodenectomy.

Paniccia A, Chapman B, Edil BH, Schulick RD.

J Vis Surg. 2016 Aug 2;2:130. doi: 10.21037/jovs.2016.07.13. eCollection 2016.


The Multidisciplinary Approach to GI Cancer Results in Change of Diagnosis and Management of Patients. Multidisciplinary Care Impacts Diagnosis and Management of Patients.

Meguid C, Schulick RD, Schefter TE, Lieu CH, Boniface M, Williams N, Vogel JD, Gajdos C, McCarter M, Edil BH.

Ann Surg Oncol. 2016 Nov;23(12):3986-3990. Epub 2016 Jun 24.


Identification of CD112R as a novel checkpoint for human T cells.

Zhu Y, Paniccia A, Schulick AC, Chen W, Koenig MR, Byers JT, Yao S, Bevers S, Edil BH.

J Exp Med. 2016 Feb 8;213(2):167-76. doi: 10.1084/jem.20150785. Epub 2016 Jan 11.


Pancreatic Neuroendocrine Tumors: an Update.

Paniccia A, Edil BH, Schulick RD.

Indian J Surg. 2015 Oct;77(5):395-402. doi: 10.1007/s12262-015-1360-2. Epub 2015 Oct 13.


Establishing a framework for building multidisciplinary programs.

Meguid C, Ryan CE, Edil BH, Schulick RD, Gajdos C, Boniface M, Schefter TE, Purcell WT, McCarter M.

J Multidiscip Healthc. 2015 Dec 2;8:519-26. doi: 10.2147/JMDH.S96415. eCollection 2015.


Immunotherapy for pancreatic ductal adenocarcinoma: an overview of clinical trials.

Paniccia A, Merkow J, Edil BH, Zhu Y.

Chin J Cancer Res. 2015 Aug;27(4):376-91. doi: 10.3978/j.issn.1000-9604.2015.05.01. Review.


Laparoscopic pancreaticoduodenectomy: a descriptive and comparative review.

Merkow J, Paniccia A, Edil BH.

Chin J Cancer Res. 2015 Aug;27(4):368-75. doi: 10.3978/j.issn.1000-9604.2015.06.05. Review.


Predictors for Surgical Referral in Patients With Pancreatic Cystic Lesions Undergoing Endoscopic Ultrasound: Results From a Large Multicenter Cohort Study.

Ge PS, Gaddam S, Keach JW, Mullady D, Fukami N, Edmundowicz SA, Azar RR, Shah RJ, Murad FM, Kushnir VM, Ghassemi KF, Sedarat A, Watson RR, Amateau SK, Brauer BC, Yen RD, Hosford L, Hollander T, Donahue TR, Schulick RD, Edil BH, McCarter MD, Gajdos C, Attwell AR, Muthusamy VR, Early DS, Wani S.

Pancreas. 2016 Jan;45(1):51-7. doi: 10.1097/MPA.0000000000000386.


A combination of molecular markers and clinical features improve the classification of pancreatic cysts.

Springer S, Wang Y, Dal Molin M, Masica DL, Jiao Y, Kinde I, Blackford A, Raman SP, Wolfgang CL, Tomita T, Niknafs N, Douville C, Ptak J, Dobbyn L, Allen PJ, Klimstra DS, Schattner MA, Schmidt CM, Yip-Schneider M, Cummings OW, Brand RE, Zeh HJ, Singhi AD, Scarpa A, Salvia R, Malleo G, Zamboni G, Falconi M, Jang JY, Kim SW, Kwon W, Hong SM, Song KB, Kim SC, Swan N, Murphy J, Geoghegan J, Brugge W, Fernandez-Del Castillo C, Mino-Kenudson M, Schulick R, Edil BH, Adsay V, Paulino J, van Hooft J, Yachida S, Nara S, Hiraoka N, Yamao K, Hijioka S, van der Merwe S, Goggins M, Canto MI, Ahuja N, Hirose K, Makary M, Weiss MJ, Cameron J, Pittman M, Eshleman JR, Diaz LA Jr, Papadopoulos N, Kinzler KW, Karchin R, Hruban RH, Vogelstein B, Lennon AM.

Gastroenterology. 2015 Nov;149(6):1501-10. doi: 10.1053/j.gastro.2015.07.041. Epub 2015 Aug 4.


Suboptimal accuracy of carcinoembryonic antigen in differentiation of mucinous and nonmucinous pancreatic cysts: results of a large multicenter study.

Gaddam S, Ge PS, Keach JW, Mullady D, Fukami N, Edmundowicz SA, Azar RR, Shah RJ, Murad FM, Kushnir VM, Watson RR, Ghassemi KF, Sedarat A, Komanduri S, Jaiyeola DM, Brauer BC, Yen RD, Amateau SK, Hosford L, Hollander T, Donahue TR, Schulick RD, Edil BH, McCarter M, Gajdos C, Attwell A, Muthusamy VR, Early DS, Wani S.

Gastrointest Endosc. 2015 Dec;82(6):1060-9. doi: 10.1016/j.gie.2015.04.040. Epub 2015 Jun 12.


Characteristics of 10-Year Survivors of Pancreatic Ductal Adenocarcinoma.

Paniccia A, Hosokawa P, Henderson W, Schulick RD, Edil BH, McCarter MD, Gajdos C.

JAMA Surg. 2015 Aug;150(8):701-10. doi: 10.1001/jamasurg.2015.0668.


Total Laparoscopic Pancreaticoduodenectomy: A Single-Institutional Experience.

Paniccia A, Schulick RD, Edil BH.

Ann Surg Oncol. 2015 Dec;22(13):4380-1. doi: 10.1245/s10434-015-4450-2. Epub 2015 Apr 18.


Challenges of minimally invasive pancreas surgery growth with such a high learning curve.

Edil BH, Schulick RD.

JAMA Surg. 2015 May;150(5):423. doi: 10.1001/jamasurg.2015.32. No abstract available.


Expression of the Novel Costimulatory Molecule B7-H5 in Pancreatic Cancer.

Byers JT, Paniccia A, Kaplan J, Koenig M, Kahn N, Wilson L, Chen L, Schulick RD, Edil BH, Zhu Y.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1574-9. doi: 10.1245/s10434-014-4293-2. Epub 2014 Dec 18.


Neoadjuvant FOLFIRINOX application in borderline resectable pancreatic adenocarcinoma: a retrospective cohort study.

Paniccia A, Edil BH, Schulick RD, Byers JT, Meguid C, Gajdos C, McCarter MD.

Medicine (Baltimore). 2014 Dec;93(27):e198. doi: 10.1097/MD.0000000000000198.


Update on pancreatic neuroendocrine tumors.

McKenna LR, Edil BH.

Gland Surg. 2014 Nov;3(4):258-75. doi: 10.3978/j.issn.2227-684X.2014.06.03. Review.


PD-1/PD-L1 blockade together with vaccine therapy facilitates effector T-cell infiltration into pancreatic tumors.

Soares KC, Rucki AA, Wu AA, Olino K, Xiao Q, Chai Y, Wamwea A, Bigelow E, Lutz E, Liu L, Yao S, Anders RA, Laheru D, Wolfgang CL, Edil BH, Schulick RD, Jaffee EM, Zheng L.

J Immunother. 2015 Jan;38(1):1-11. doi: 10.1097/CJI.0000000000000062.


Laparoscopic pancreaticojejunostomy using a barbed suture: a novel technique.

Edil BH, Cooper MA, Makary MA.

J Laparoendosc Adv Surg Tech A. 2014 Dec;24(12):887-91. doi: 10.1089/lap.2014.0053.


A safety and feasibility study of an allogeneic colon cancer cell vaccine administered with a granulocyte-macrophage colony stimulating factor-producing bystander cell line in patients with metastatic colorectal cancer.

Zheng L, Edil BH, Soares KC, El-Shami K, Uram JN, Judkins C, Zhang Z, Onners B, Laheru D, Pardoll D, Jaffee EM, Schulick RD.

Ann Surg Oncol. 2014 Nov;21(12):3931-7. doi: 10.1245/s10434-014-3844-x. Epub 2014 Jun 19.


Fertility preservation in a patient with benign multicystic peritoneal mesothelioma.

Al-Safi ZA, Edil BH, Post MD, Pearlman NW, Alvero R.

J Surg Oncol. 2014 Sep;110(4):372-4. doi: 10.1002/jso.23653. Epub 2014 May 26.


Vaccine therapy for pancreatic cancer.

Salman B, Zhou D, Jaffee EM, Edil BH, Zheng L.

Oncoimmunology. 2013 Dec 1;2(12):e26662. Epub 2013 Oct 22. Review.


Senior adult oncology, version 2.2014: clinical practice guidelines in oncology .

Hurria A, Wildes T, Blair SL, Browner IS, Cohen HJ, Deshazo M, Dotan E, Edil BH, Extermann M, Ganti AK, Holmes HM, Jagsi R, Karlekar MB, Keating NL, Korc-Grodzicki B, McKoy JM, Medeiros BC, Mrozek E, O'Connor T, Rugo HS, Rupper RW, Silliman RA, Stirewalt DL, Tew WP, Walter LC, Weir AB 3rd, Bergman MA, Sundar H.

J Natl Compr Canc Netw. 2014 Jan;12(1):82-126.


Intercellular adhesion molecule-1 mediates murine colon adenocarcinoma invasion.

Howard K, Lo KK, Ao L, Gamboni F, Edil BH, Schulick R, Barnett CC Jr.

J Surg Res. 2014 Mar;187(1):19-23. doi: 10.1016/j.jss.2013.11.001. Epub 2013 Nov 8.


Longer Course of Induction Chemotherapy Followed by Chemoradiation Favors Better Survival Outcomes for Patients With Locally Advanced Pancreatic Cancer.

Faisal F, Tsai HL, Blackford A, Olino K, Xia C, De Jesus-Acosta A, Le DT, Cosgrove D, Azad N, Rasheed Z, Diaz LA Jr, Donehower R, Laheru D, Hruban RH, Fishman EK, Edil BH, Schulick R, Wolfgang C, Herman J, Zheng L.

Am J Clin Oncol. 2016 Feb;39(1):18-26. doi: 10.1097/COC.0000000000000022.


Diffuse replacement of pancreatic parenchyma by intraductal papillary mucinous neoplasm.

Amateau SK, McManus MC, Edil BH.

Endoscopy. 2013;45 Suppl 2 UCTN:E407-9. doi: 10.1055/s-0033-1344993. Epub 2013 Nov 27. No abstract available.


Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate.

McCall CM, Shi C, Cornish TC, Klimstra DS, Tang LH, Basturk O, Mun LJ, Ellison TA, Wolfgang CL, Choti MA, Schulick RD, Edil BH, Hruban RH.

Am J Surg Pathol. 2013 Nov;37(11):1671-7. doi: 10.1097/PAS.0000000000000089.


Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma.

Herman JM, Fan KY, Wild AT, Wood LD, Blackford AL, Donehower RC, Hidalgo M, Schulick RD, Edil BH, Choti MA, Hruban RH, Pawlik TM, Cameron JL, Laheru DA, Iacobuzio-Donahue CA, Wolfgang CL.

Int J Radiat Oncol Biol Phys. 2013 Nov 1;87(3):458-9. doi: 10.1016/j.ijrobp.2013.06.2039. No abstract available.


Low total lymphocyte count is associated with poor survival in patients with resected pancreatic adenocarcinoma receiving a GM-CSF secreting pancreatic tumor vaccine.

Schueneman AJ, Sugar EA, Uram J, Bigelow E, Herman JM, Edil BH, Jaffee EM, Zheng L, Laheru DA.

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S725-30. doi: 10.1245/s10434-013-3262-5. Epub 2013 Sep 18.


Advancements in pancreatic neuroendocrine tumors.

Sadaria MR, Hruban RH, Edil BH.

Expert Rev Gastroenterol Hepatol. 2013 Jul;7(5):477-90. doi: 10.1586/17474124.2013.811058. Review.


Phase 2 study of erlotinib combined with adjuvant chemoradiation and chemotherapy in patients with resectable pancreatic cancer.

Herman JM, Fan KY, Wild AT, Hacker-Prietz A, Wood LD, Blackford AL, Ellsworth S, Zheng L, Le DT, De Jesus-Acosta A, Hidalgo M, Donehower RC, Schulick RD, Edil BH, Choti MA, Hruban RH, Pawlik TM, Cameron JL, Laheru DA, Wolfgang CL.

Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):678-85. doi: 10.1016/j.ijrobp.2013.03.032.


A single institution's 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram.

Ellison TA, Wolfgang CL, Shi C, Cameron JL, Murakami P, Mun LJ, Singhi AD, Cornish TC, Olino K, Meriden Z, Choti M, Diaz LA, Pawlik TM, Schulick RD, Hruban RH, Edil BH.

Ann Surg. 2014 Feb;259(2):204-12. doi: 10.1097/SLA.0b013e31828f3174.

Supplemental Content

Support Center